S.H. Capetta

Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story

Artificial intelligence in drug development: present status and future prospects

The use of spirocyclic scaffolds in drug discovery

Model Systems for Fluorescence and Singlet Oxygen Quenching by Metalloporphyrins

Data-Mining for Sulfur and Fluorine: An Evaluation of Pharmaceuticals To Reveal Opportunities for Drug Design and Discovery

The Organocatalytic Approach to Enantiopure 2H‐ and 3H‐Pyrroles: Inhibitors of the Hedgehog Signaling Pathway

Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer’s Disease

Organokatalytische Synthese von enantiomerenreinen 2H‐ und 3H‐Pyrrolen: Inhibitoren des Hedgehog‐Signalwegs

Activatable Photosensitizers for Imaging and Therapy

Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy

Hit Identification and Optimization in Virtual Screening: Practical Recommendations Based on a Critical Literature Analysis

Discovery and Optimization of a Novel Spiropyrrolidine Inhibitor of β-Secretase (BACE1) through Fragment-Based Drug Design

Use of Ag(II) as a removable template in porphyrin chemistry: diol cleavage products of [meso-tetraphenyl-2,3-cis-diolchlorinato]silver(II)